SPIA
FSTX

Steward Partners Investment Advisory’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,500
Closed -$27.1K – 7512
2021
Q1 		$27.1K Buy
+2,500
New +$24.3K ﹤0.01% 2329

Other funds holding FSTX

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Steward Partners Investment Advisory's FSTX Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2021, closing a stake of 2,500 shares — an estimated $27.1K sold.

Steward Partners Investment Advisory first reported a position in FSTX in Q1 2021 and held it in 1 quarter. The position peaked at $27.1K in Q1 2021. 41 funds tracked by Wall St. Rank hold FSTX as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 2,500 F-star Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $27.1K.
  • Steward Partners Investment Advisory first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's F-star Therapeutics, Inc. Common Stock position peaked at $27.1K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.